27903410|t|Long-chain n-3 PUFA supplied by the usual diet decrease plasma stearoyl-CoA desaturase index in non-hypertriglyceridemic older adults at high vascular risk
27903410|a|The activity of stearoyl-CoA desaturase-1 (SCD1), the central enzyme in the synthesis of monounsaturated fatty acids (MUFA), has been associated with de novo lipogenesis. In experimental models SCD1 is down-regulated by polyunsaturated fatty acids (PUFA), but clinical studies are scarce. The effect of long-chain n-3 PUFA (LCn-3PUFA) supplied by the regular diet, in the absence of fatty fish or fish oil supplementation, remains to be explored. We related 1-y changes in plasma SCD1 index, as assessed by the C16:1n-7 / C16:0 ratio, to both adiposity traits and nutrient intake changes in a sub-cohort (n = 243) of non-hypertriglyceridemic subjects of the PREDIMED (PREvención con DIeta MEDiterranea) trial. After adjustment for confounders, including changes in fasting triglycerides, plasma SCD1 index increased in parallel with body weight (0.221 [95% confidence interval, 0.021 to 0.422], P = 0.031) and BMI (0.115 [0.027 to 0.202], P = 0.011). Additionally, dietary LCn-3PUFA (but not MUFA or plant-derived PUFA) were associated with decreased plasma SCD1 index (-0.544 [-1.044 to -0.043], P = 0.033, for each 1 g/d- increase in LCn-3PUFA). No associations were found for other food groups, but there was a trend for fatty fish intake (-0.083 [-0.177 to 0.012], P = 0.085, for each 10 g/d- increase). Our data add clinical evidence on the down-regulation of plasma SCD1 index by LCn-3PUFA in the context of realistic changes in fish consumption in the customary, non-supplemented diet. http://www.Controlled-trials.com/ISRCTN35739639.
27903410	0	19	Long-chain n-3 PUFA	T109,T121,T123	C0015689
27903410	20	28	supplied	T052	C1999230
27903410	36	41	usual	T080	C3538928
27903410	42	46	diet	T168	C0012155
27903410	47	55	decrease	T081	C0547047
27903410	56	86	plasma stearoyl-CoA desaturase	T116,T126	C0038233
27903410	87	92	index	T170	C0918012
27903410	96	120	non-hypertriglyceridemic	T033	C0243095
27903410	121	133	older adults	T098	C0001792
27903410	142	150	vascular	T023	C0005847
27903410	151	155	risk	T078	C0035647
27903410	160	168	activity	T044	C0243102
27903410	172	197	stearoyl-CoA desaturase-1	T116,T126	C2002916
27903410	199	203	SCD1	T116,T126	C2002916
27903410	210	224	central enzyme	T116,T126	C0014442
27903410	232	241	synthesis	T052	C1883254
27903410	245	272	monounsaturated fatty acids	T109,T123	C0015687
27903410	274	278	MUFA	T109,T123	C0015687
27903410	290	305	associated with	T080	C0332281
27903410	306	313	de novo	T078	C1515568
27903410	314	325	lipogenesis	T040	C1563744
27903410	330	349	experimental models	T170	C0086272
27903410	350	354	SCD1	T116,T126	C2002916
27903410	358	372	down-regulated	T044	C0013081
27903410	376	403	polyunsaturated fatty acids	T109,T123	C0032615
27903410	405	409	PUFA	T109,T123	C0032615
27903410	416	432	clinical studies	T062	C0008972
27903410	449	455	effect	T080	C1280500
27903410	459	478	long-chain n-3 PUFA	T109,T121,T123	C0015689
27903410	480	489	LCn-3PUFA	T109,T121,T123	C0015689
27903410	491	499	supplied	T052	C1999230
27903410	507	519	regular diet	T168	C0012155
27903410	528	535	absence	T169	C0332197
27903410	539	549	fatty fish	T168	C0453017
27903410	553	561	fish oil	T168	C0556145
27903410	562	578	supplementation,	T168	C0242295
27903410	606	613	related	T080	C0439849
27903410	618	625	changes	T169	C0392747
27903410	629	640	plasma SCD1	T116,T126	C2002916
27903410	641	646	index	T170	C0918012
27903410	651	659	assessed	T052	C1516048
27903410	667	675	C16:1n-7	T109	C0069966
27903410	678	683	C16:0	T109,T123	C0030234
27903410	684	689	ratio	T081	C0456603
27903410	699	708	adiposity	T032	C1563743
27903410	709	715	traits	T032	C0599883
27903410	720	735	nutrient intake	T033	C1287879
27903410	736	743	changes	T169	C0392747
27903410	749	759	sub-cohort	T098	C0599755
27903410	773	797	non-hypertriglyceridemic	T033	C0243095
27903410	798	806	subjects	T098	C0080105
27903410	814	864	PREDIMED (PREvención con DIeta MEDiterranea) trial	T062	C0008976
27903410	910	917	changes	T169	C0392747
27903410	921	928	fasting	T033	C0015663
27903410	929	942	triglycerides	T109,T123	C0041004
27903410	944	955	plasma SCD1	T116,T126	C2002916
27903410	956	961	index	T170	C0918012
27903410	962	971	increased	T081	C0205217
27903410	989	1000	body weight	T032	C0005910
27903410	1013	1032	confidence interval	T081	C0009667
27903410	1066	1069	BMI	T201	C1305855
27903410	1121	1128	dietary	T168	C0012155
27903410	1129	1138	LCn-3PUFA	T109,T121,T123	C0015689
27903410	1148	1152	MUFA	T109,T123	C0015687
27903410	1156	1174	plant-derived PUFA	T109	C1318902
27903410	1181	1196	associated with	T080	C0332281
27903410	1197	1206	decreased	T081	C0205216
27903410	1207	1218	plasma SCD1	T116,T126	C2002916
27903410	1219	1224	index	T170	C0918012
27903410	1280	1288	increase	T169	C0442805
27903410	1292	1301	LCn-3PUFA	T109,T121,T123	C0015689
27903410	1307	1319	associations	T080	C0439849
27903410	1341	1345	food	T168	C0016452
27903410	1346	1352	groups	T078	C0441833
27903410	1380	1390	fatty fish	T168	C0453017
27903410	1391	1397	intake	T169	C1512806
27903410	1453	1461	increase	T169	C0442805
27903410	1468	1472	data	T078	C1511726
27903410	1477	1485	clinical	T080	C0205210
27903410	1486	1494	evidence	T078	C3887511
27903410	1502	1517	down-regulation	T044	C0013081
27903410	1521	1532	plasma SCD1	T116,T126	C2002916
27903410	1533	1538	index	T170	C0918012
27903410	1542	1551	LCn-3PUFA	T109,T121,T123	C0015689
27903410	1559	1566	context	T078	C0449255
27903410	1580	1587	changes	T169	C0392747
27903410	1591	1595	fish	T013	C0016163
27903410	1596	1607	consumption	T052	C2983605
27903410	1615	1624	customary	T080	C3538928
27903410	1626	1642	non-supplemented	T033	C0243095
27903410	1643	1647	diet	T168	C0012155